Crohns Disease News




 

 

Crohns Disease News Archive

16-Dec-2006

 

Research & Markets: One of UCB's biggest-selling Products, Keppra, Achieved Sales Growth of 34% (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of the Espicom Business Intelligence Ltd report: UCB Prospects to 2010 to their offering.

Research and Markets : The Battle between Cimzia and Humira Will Depend On Efficacy, Convenience and Cost for ... (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Commercial and Pipeline Insight: Inflammatory Bowel Disease - Competition Increases for the Biologics to their offering.

Research & Markets: One of UCB´s biggest-selling Products, Keppra, Achieved Sales Growth of 34% (wallstreet:online AG)
Research and Markets (http://www.researchandmarkets.com/reports/c47159) has announced the addition

Holidays bring back fond memories (The Troy Messenger)
Thanksgivings just seem to run together and all the memories blend into family and food. At least that's what many people say. ?My most memorable Thanksgiving was about 10 years ago when all of my children and grandchildren and great-grandchildren were there,? said Elsie Lindsey.

Calendar (Baltimore Sun)
Events, screenings, support groups and more

Back to Crohns Disease

Back to Crohns Disease News Archive

 

 

 

 

 

 

 

The articles and content provided on this website have been contributed by guest authors, and may not reflect the views, opinions, thoughts or beliefs of http://www.crohns-disease.me.uk/ or its staff. We are not responsible for copyright infringements by columnists, writers and authors. We do not necessarily endorse or promote the services, advice or products by, from and mentioned by any authors, writers or columnists. http://www.crohns-disease.me.uk/ will not be liable for any loss or damage suffered by a user through the user's reliance on information and advice gained through the articles, interviews, stories, columns, and any and all writings viewed on this website.